Shein shares dropped 10% in Hong Kong trading because Australia and New Zealand recalled a contact lens cleaning solution. Not clothing. Not accessories. Contact lens cleaner. The fast-fashion company that built an empire on $3 crop tops apparently also sells medical supplies now, which is exactly what you want when shopping between tube tops and pleather miniskirts.
The product got recalled for contamination concerns. Contamination of what, exactly, remains unclear. But when you're buying eye care products from a company that ships dresses for less than a latte, you've already made your peace with risk. This is the same consumer base that trusts Shein's size charts. They fear nothing.
Retail traders watched their positions crater because two countries most Americans couldn't locate on a map decided a niche product might have quality issues. The technical analysis said nothing about this. The chart patterns gave no warning. The 50-day moving average did not account for contaminated saline solution in the Southern Hemisphere. Turns out—and I'm just spitballing here—drawing lines on a stock chart doesn't predict product recalls.
Some poor bastard probably had his whole portfolio in Shein calls, convinced he'd cracked the code on fast-fashion momentum, only to get wiped out by Australian regulatory agencies worried about eyeball safety. That's the market. You think you're trading fashion trends, but you're actually exposed to cross-border medical device compliance risk.
The stock will probably recover by Tuesday. Retail will buy the dip. They'll convince themselves this was just noise, just headline risk, just temporary fear. They'll tell themselves the fundamentals haven't changed.
The fundamentals are that Shein sells contact lens cleaner next to halter tops for $4.99, and nobody questioned this business model until someone's cornea was at stake.
Photo by on Unsplash
Leave a Comment